These results suggest that planning a therapeutic diet with high protein and fermented vegetables may be a valid strategy for those with PNPLA3 risk genotypes and NAFLD, and warrants future interventional studies. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.